Solid Tumor Malignancies Clinical Trial
Official title:
Phase I Safety Study of Intratumoral Injection of Clostridium Novyi-NT Spores in Patients With Treatment-refractory Solid Tumor Malignancies
This protocol will examine the safety of intratumoral administration of Clostridium Novyi-NT spores in patients with treatment-refractory solid tumor malignancies. This investigational study will measure anti-tumor activity of C. novyi-NT administered intratumoral in patients with treatment-refractory solid tumor malignancies.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT04668833 -
ALI Post Radiation Therapy in Patients With Lung and Esophageal Canter
|
Phase 2 | |
| Recruiting |
NCT05085548 -
ProAgio in Previously Treated Advanced Pancreatic Cancer and Other Solid Tumor Malignancies
|
Phase 1 | |
| Completed |
NCT00310895 -
Safety and Dose Study of GRN163L Administered to Patients With Refractory or Relapsed Solid Tumor Malignancies
|
Phase 1 | |
| Completed |
NCT01183364 -
A Dose Escalation Study of STA-9090 and Docetaxel in Patients With Solid Tumors
|
Phase 1 | |
| Terminated |
NCT00195156 -
Treatment With ATRA-IV and Depakote in Patients With Advanced Solid Tumor Malignancies
|
Phase 1 | |
| Terminated |
NCT01290380 -
A Study to Evaluate the Effects of ASA404 Alone or in Combination With Taxane-based Chemotherapies on the Pharmacokinetics of Drugs in Patients With Advanced Solid Tumor Malignancies
|
Phase 1 | |
| Terminated |
NCT01118819 -
Safety Study of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies
|
Phase 1 |